Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells - Wikidata - wikimedia - TriplyDB

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells

http://www.wikidata.org/entity/Q37205578

about

In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening Probing the behaviors of gold nanorods in metastatic breast cancer cells based on UV-vis-NIR absorption spectroscopy.Comparison of cantharidin toxicity in breast cancer cells to two common chemotherapeutics Proteomic studies in breast cancer (Review).Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells.The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells DNA damage and breast cancer Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma Synthesis, characterization, and evaluation of cis-diphenyl pyridineamine platinum(II) complexes as potential anti-breast cancer agents Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma.Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient.Taxane benefit in breast cancer--a role for grade and chromosomal stability.Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells.Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation.Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.Regulation of paclitaxel sensitivity in prostate cancer cells by PTEN/maspin signaling.High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.

P2860

Q28545989-19BC4E98-B54D-4008-BF46-142850232C23 Q34182128-53C2951B-E853-4B91-8628-E6845560CACD Q34267632-7DCE90D3-D374-4DE4-A3B3-A27B08658C8B Q34319634-EBB428D5-467B-4560-ADC8-27836CE7BE5C Q34590906-684D555B-A752-4EEE-9D01-DFEC3E328B44 Q35176066-6373F5EF-4D8C-4D53-82C9-322CF1CAA0A3 Q35201664-828C2A6A-1D13-4EC2-A36F-363270F426BE Q35835123-7CEC19DD-F9B1-4BDF-9D61-10CE97AED919 Q35848667-518F803A-BB3A-4209-908A-1FFDE0168196 Q36270717-079AB1C7-E49A-48CE-A893-53BC9D72B6E6 Q36424035-E3F6F008-CE96-45CC-ABE0-ED4AF333DE1D Q36750990-735D852F-9804-4681-9543-118A36CD5BAC Q36905747-F43A4740-908A-46AA-ABAB-EA4A87F0586E Q37347521-8158F845-945E-44F6-BBBF-3357B72C7667 Q38104568-81CEADB8-D615-4D98-ACC1-56A95A92D160 Q38762630-1BBCC97C-1F8F-41CC-8F47-864B577531B3 Q38852131-BE001EB1-805C-467D-996A-1BFAB33E731F Q38962304-DA6FC7E4-58E4-412F-A075-74BA0FBCADF6 Q39365972-72889C56-0B5D-4AD1-B01D-2C5105AC65D8 Q40931694-EBE42557-6A22-4C8B-94AE-15B706C5CAF8 Q42739081-AAA473FB-F519-4234-A5EE-ACE77F66E91B Q43675251-31130771-1D7A-455E-9E5F-9A609791C367 Q47961317-AA99E8C0-10FA-4BAB-AFD1-3B1C734A38FA Q48227330-27B7CB5F-88C2-4311-9D84-BD5F30E25531

P2860

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells

http://www.wikidata.org/entity/Q37205578

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prediction of paclitaxel sensi ...... y in human breast cancer cells

@en

Prediction of paclitaxel sensi ...... in human breast cancer cells.

@nl

type

label

Prediction of paclitaxel sensi ...... y in human breast cancer cells

@en

Prediction of paclitaxel sensi ...... in human breast cancer cells.

@nl

prefLabel

Prediction of paclitaxel sensi ...... y in human breast cancer cells

@en

Prediction of paclitaxel sensi ...... in human breast cancer cells.

@nl

P1433

Q37205578-894BD40D-DB6D-476E-8F5E-B99369D806E4

P1476

Q37205578-7DC23C03-CA27-4CFD-BC14-7225CF0A2CBE

P2093

Q37205578-000B9AE9-75F8-4905-8DA6-F837B70B2E24

Q37205578-35F0FF8F-F41D-456B-BCDB-6DAACBF05FA8

Q37205578-58185B50-30E8-411D-AFDF-AA8794BCDE0E

Q37205578-72A1D129-5667-41E2-8C2B-8AC51475B530

Q37205578-75491444-D860-427F-8B88-BF324F93013E

Q37205578-7BA63AB5-A677-49B6-BD85-EE6F74F75205

Q37205578-82A2420D-3795-49E4-998A-0F6F0AB4797F

Q37205578-8C806647-EB71-4778-8EE8-EC78AFB1BF31

Q37205578-9004FAD7-14D9-4A6C-B9CE-CD5E577DE067

Q37205578-A273B6EB-874D-46FF-A60A-D2A5D738E613

P2860

Q37205578-104C2E13-D2FF-4C83-AE31-5FF24F85CECF

Q37205578-1261ADC0-7488-41E9-850B-4B6413CB03C9

Q37205578-15F58ACF-B86A-45C2-995A-75D654BB599B

Q37205578-3BF9084B-A975-4DA9-B3ED-BED786C2F41A

Q37205578-481C6E76-9976-4AB2-B0D1-0C735B342255

Q37205578-50004AFC-4EB6-45CF-9F7D-3FC8E6EE9BCA

Q37205578-5440BBD2-7BC7-427E-94C8-349FEB79D505

Q37205578-5BC68E47-D32E-449C-8D25-F7D3A0813399

Q37205578-5C43959D-FB17-4BF9-9074-9C9D0C366389

Q37205578-5CBA6670-F936-4033-BE88-27767846D867

P2888

Q37205578-2E894683-D3DE-4F11-A25B-F84763A0B74C

P304

Q37205578-6A2E0F45-6B57-4538-9DA9-01A898675B12

P31

Q37205578-055B93D7-8B20-4D25-B6F7-1773CE451AB6

P356

Q37205578-0FBED892-C682-4BF6-8363-4469432824E0

P433

Q37205578-95492139-72EB-45DB-B61D-AD682DBCC087

P478

Q37205578-DC28C1B8-7CEE-4F01-80F2-19ABED93508B

P577

Q37205578-FF7627DB-DBD7-4FA0-95A8-4823C217A1D4

P5875

Q37205578-A9FFE83E-426A-4017-80AF-9732942AD0E4

P6179

Q37205578-E7A32278-6B35-4D5E-A20C-39B8E90E454A

P698

Q37205578-74AFBE9A-C4A5-4C4D-95DC-4011C575F867

P932

Q37205578-E9436430-9068-4578-A1B4-D1492841911F

P356

P1433

Breast Cancer Research

P1476

Prediction of paclitaxel sensi ...... y in human breast cancer cells

@en

P2093

Aya Katayama

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Hideki Ishihara

http://www.w3.org/2001/XMLSchema#string

Keigo Gohda

http://www.w3.org/2001/XMLSchema#string

Naoto T Ueno

http://www.w3.org/2001/XMLSchema#string

Satoshi Nakayama

http://www.w3.org/2001/XMLSchema#string

Shinzaburo Noguchi

http://www.w3.org/2001/XMLSchema#string

Takeshi Takahashi

http://www.w3.org/2001/XMLSchema#string

Tamotsu Sudo

http://www.w3.org/2001/XMLSchema#string

Tomokazu Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of proliferation in invasive breast cancer: a review

Mitotic kinases as regulators of cell division and its checkpoints

Cyclin-dependent kinases: engines, clocks, and microprocessors

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together.

Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases.

Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers.

Role of microtubules in the distribution of the Golgi apparatus: effect of taxol and microinjected anti-alpha-tubulin antibodies

P2888

P304

R12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2231

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24037304

http://www.w3.org/2001/XMLSchema#string

P6179

1036529065

http://www.w3.org/2001/XMLSchema#string

P698

19239702

http://www.w3.org/2001/XMLSchema#string

P932

2687717

http://www.w3.org/2001/XMLSchema#string